35th Vicenza Course on AKI and CRRT, Vicenza

Xenios had been invited by Fresenius Medical Care to fairly participate in the Fresenius fair presentation.

The dramatic story of Canadian Melissa Benoit, who lived for six days without a lung, shows a view of a new chapter in the history of medical technology. The novalung iLA membrane lung, which replaced the functions of the lung, is a product of XENIOS AG. As a strategic ...

The leakage of hydrogen peroxide (H2O2) through the heat exchanger membrane of medos hilite oxygenators has been successfully tested. Over the past year a number of manufacturers of oxygenators reported problems with exceeding the specified limit values for H2O2 in the blood. The ability of hilite oxygenators to meet the specified ...

XENIOS AG, the technology and therapy leader in lung and heart assist becomes part of Fresenius Medical Care & Co. KGaA, Germany’s largest medical device company. – www.xenios-ag.com XENIOS is driving innovation in minimally invasive lung and heart assist, and is first to offer a complete product range that runs on ...

ESICM 2016 congress October 1-5 in Milano, Italy

Xenios looks back on a very successful ESICM 2016 congress October 1-5 in Milano, Italy. Extracorporeal CO2 removal was a main topic during the scientific lectures where the outstanding potential of this therapy to prevent ventilator-induced lung damage was discussed. On the booth we presented the Novalung therapy (interventional ...

30th EACTS Annual Meeting 1-5 October 2016. CCIB, Barcelona, Spain

Xenios at EACTS 2016 Barcelona – we presented our UNIQUE XENIOS PLATFORM and our new XENIOS CAMPUS